Maravai LifeSciences Holdings (FRA:MAR) Valuation Rank


FRA:MAR Maravai LifeSciences Holdings Inc FRA:MAR
63 GF Score
Price €5.10
GF Value €3.30
Valuation Significantly Overvalued
! 8 Warning Signs
View Full Analysis

What is Maravai LifeSciences Holdings Valuation Rank?

The Valuation Rank measures the current valuation of a business relative to other companies in the same industry and its own historical valuation. The companies are split in equal numbers and then ranked from 1 to 10, with 10 as the most undervalued and 1 as the most overvalued.

  1. Three factors:
    • Absolute valuation (medpsvalue) relative to current stock price, rank among all companies
    • Historical valuation over the past 10 years. Rank pe, ps, pocf, ev2ebit over their own historical values
    • Industry relative valuation
  2. Companies without enough data is not ranked
  3. Companies with negative earnings are ranked lower

These three factors are used to calculate the value score for every eligible company, with values from 1 to 10. The final ranked companies are split in equal numbers and ranked from 1 to 10, with 10 as the most undervalued, and 1 as the most overvalued. The numbers of companies in each rank are the same.

Maravai LifeSciences Holdings Valuation Rank Related Terms

FRA:MAR
63GF Score
Maravai LifeSciences Holdings Inc FRA:MAR
Valuation Rank is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Maravai LifeSciences Holdings (FRA:MAR) Overvalued in 2026?

Based on GuruFocus' analysis, Maravai LifeSciences Holdings stock appears to be overvalued. The current stock price of €5.10 is trading 54.5% above its estimated GF Value™ of €3.30. GuruFocus considers Maravai LifeSciences Holdings to be Significantly Overvalued.

Key valuation signals for FRA:MAR:

  • Valuation Rank:
  • GF Value™: €3.30 vs. price of €5.10 (54.5% above fair value)
  • GF Score™: 63/100 with 8 warning signs

No single metric tells the full story. See the FRA:MAR stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Maravai LifeSciences Holdings Business Description

Other Exchanges MRVI:USA
Address 10770 Wateridge Circle, Suite 200, San Diego, CA, USA, 92121
Maravai LifeSciences Holdings Inc is a life sciences company providing products and services to enable the development of drugs, therapeutics, vaccines and diagnostics, and to support research on human disease. Its product portfolio includes complex nucleic acids, custom enzymes and antibody-based solutions for therapeutic, vaccine, diagnostic and biopharmaceutical production applications. The Company operates through two segments: TriLink, which generates maximum revenue from North America and provides nucleic acid products and services including mRNA, oligonucleotides and related technologies; and Cygnus, which provides biologics safety testing products and services including host cell protein ELISA kits, impurity detection assays and related reagents and services.
63GF Score

Get the complete analysis for FRA:MAR

Valuation Rank is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€5.10
Price
€3.30
GF Value